Does North Carolina Medicaid cover Wegovy and Zepbound in 2026?

Yes, with prior authorization. As of Oct 23, 2026, North Carolina Medicaid covers GLP-1 drugs for obesity, under criteria such as BMI.

What this covers

Coverage of GLP-1 drugs for obesity alone under North Carolina’s fee-for-service Medicaid drug rules, as the state publishes them. The plan decides each request.

North Carolina’s rule

In plain words

Covered with prior authorization

Prior authorization with clinical criteria. Coverage was cut Oct 1, 2025 and reinstated Dec 12, 2025.

Coverage was cut Oct 1, 2025 and reinstated Dec 12, 2025.

Source

NC Medicaid PDL, eff. Oct 1, 2026 (opens in new tab). Checked Oct 23, 2026.

Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization. Social Security Act §1927(d)(1)(A) and (d)(2)(A), 42 U.S.C. 1396r-8(d) (opens in new tab).

What changed

Questions this page answers

Does North Carolina Medicaid cover Wegovy and Zepbound for weight loss?

Yes, with prior authorization. As of Oct 23, 2026, North Carolina Medicaid covers GLP-1 drugs for obesity, under criteria such as BMI. Prior authorization with clinical criteria. Coverage was cut Oct 1, 2025 and reinstated Dec 12, 2025.

Has North Carolina’s rule changed recently?

Dec 12, 2025: NC Medicaid reinstated GLP-1 coverage for obesity, cut on Oct 1, 2025.

Where does this information come from?

From NC Medicaid PDL, eff. Oct 1, 2026, read on Oct 23, 2026. Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization.

Kymata Health reads each state’s own Medicaid documents. See every state on the map.

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.